News

FDA Commissioner Robert Califf, MD, recently said the need to address misinformation is “probably the most difficult issue in my career.” Delivering accurate, understandable, and timely health information to the public, as well as to experts trusted by…

Expert advisers will consider today how two companies assessed potential risks with their proposed first-ever gene-editing treatment for sickle cell disease, a rare condition that disproportionately affects people of color. Read more

Jim Jones, the FDA's newly designated deputy commissioner of human foods, sees partnering with food industry stakeholders as crucial to accomplishing the food safety goals of the agency. Read more

On October 17, the FDA published “Catching Up with Califf: Advancing Nutrition, Healthy Food Options and Front-of-Package Labeling.”  Read more

The agency’s Center for Tobacco Products is hosting a two-day public meeting through today on best practices when asking the regulator to authorize new tobacco products — including e-cigarettes. Read more

The federal government machine has only enough quarters to keep food safety functioning for another month. And was it as simple as putting quarters in a machine to keep it running?   Read more

Last month was the one-year anniversary of the White House Conference and National Strategy on Hunger, Nutrition and Health. The FDA continues to make great progress on our nutrition efforts, which can help to combat the epidemic of diet-related disease…

Longer observation periods following treatment and safety considerations for chronic and frequent users are among the many research issues about xylazine-laced fentanyl that need addressing, Rachel Wightman, MD, said at a meeting on mitigating risks…

FDA Commissioner Robert Califf said Thursday that misinformation, what he sees as one of the biggest issues facing his agency’s many jurisdictions, needs an equally expansive, overlapping approach. Read more

The Reagan-Udall Foundation on Thursday published a wide-ranging report on how the FDA can combat misinformation, marking some progress on one of FDA Commissioner Robert Califf’s key goals for the agency. Read more